vs
牛津地产（IIPR）与SOLENO THERAPEUTICS INC（SLNO）财务数据对比。点击上方公司名可切换其他公司
牛津地产的季度营收约是SOLENO THERAPEUTICS INC的1.0倍（$66.7M vs $66.0M），牛津地产净利率更高（47.8% vs 39.4%，领先8.4%）
牛津地产是一家加拿大跨国企业，业务涵盖房地产投资、开发与物业管理。其投资组合包含写字楼、零售、工业、多户住宅、生命科学及酒店类资产。该公司1960年以私营企业形式创立，自2003年起成为安大略省市政雇员退休系统（OMERS）的全资子公司，总部设于多伦多，在纽约、伦敦、澳大利亚、新加坡及卢森堡均设有区域总部。
索雷诺治疗是一家临床阶段生物制药企业，专注于开发针对罕见内分泌、代谢及神经发育疾病的创新疗法，核心在研药物用于治疗普拉德-威利综合征，服务覆盖北美、欧盟等地区的罕见病患者群体。
IIPR vs SLNO — 直观对比
营收规模更大
IIPR
是对方的1.0倍
$66.0M
净利率更高
IIPR
高出8.4%
39.4%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $66.7M | $66.0M |
| 净利润 | $31.8M | $26.0M |
| 毛利率 | — | 98.3% |
| 营业利润率 | 47.8% | 33.5% |
| 净利率 | 47.8% | 39.4% |
| 营收同比 | -13.1% | — |
| 净利润同比 | -20.4% | 134.0% |
| 每股收益（稀释后） | $1.07 | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IIPRSLNO
| Q4 25 | $66.7M | — | ||
| Q3 25 | $64.7M | $66.0M | ||
| Q2 25 | $62.9M | $32.7M | ||
| Q1 25 | $71.7M | — | ||
| Q4 24 | $76.7M | — | ||
| Q3 24 | $76.5M | — | ||
| Q2 24 | $79.8M | — | ||
| Q1 24 | $75.5M | — |
净利润IIPRSLNO
| Q4 25 | $31.8M | — | ||
| Q3 25 | $29.3M | $26.0M | ||
| Q2 25 | $26.0M | $-4.7M | ||
| Q1 25 | $31.1M | — | ||
| Q4 24 | $40.0M | — | ||
| Q3 24 | $40.2M | — | ||
| Q2 24 | $42.0M | — | ||
| Q1 24 | $39.4M | — |
毛利率IIPRSLNO
| Q4 25 | — | — | ||
| Q3 25 | — | 98.3% | ||
| Q2 25 | — | 97.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率IIPRSLNO
| Q4 25 | 47.8% | — | ||
| Q3 25 | 45.5% | 33.5% | ||
| Q2 25 | 45.9% | -20.0% | ||
| Q1 25 | 47.4% | — | ||
| Q4 24 | 54.7% | — | ||
| Q3 24 | 54.8% | — | ||
| Q2 24 | 53.1% | — | ||
| Q1 24 | 55.7% | — |
净利率IIPRSLNO
| Q4 25 | 47.8% | — | ||
| Q3 25 | 45.3% | 39.4% | ||
| Q2 25 | 41.4% | -14.4% | ||
| Q1 25 | 43.3% | — | ||
| Q4 24 | 52.2% | — | ||
| Q3 24 | 52.6% | — | ||
| Q2 24 | 52.6% | — | ||
| Q1 24 | 52.3% | — |
每股收益（稀释后）IIPRSLNO
| Q4 25 | $1.07 | — | ||
| Q3 25 | $0.97 | $0.47 | ||
| Q2 25 | $0.86 | $-0.09 | ||
| Q1 25 | $1.03 | — | ||
| Q4 24 | $1.35 | — | ||
| Q3 24 | $1.37 | — | ||
| Q2 24 | $1.44 | — | ||
| Q1 24 | $1.36 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $47.6M | $498.9M |
| 总债务越低越好 | $393.7M | — |
| 股东权益账面价值 | $1.8B | $494.8M |
| 总资产 | $2.4B | $599.9M |
| 负债/权益比越低杠杆越低 | 0.21× | — |
8季度趋势，按日历期对齐
现金及短期投资IIPRSLNO
| Q4 25 | $47.6M | — | ||
| Q3 25 | $41.9M | $498.9M | ||
| Q2 25 | $104.9M | $286.8M | ||
| Q1 25 | $133.3M | — | ||
| Q4 24 | $151.2M | — | ||
| Q3 24 | $172.4M | — | ||
| Q2 24 | $160.9M | — | ||
| Q1 24 | $173.5M | — |
总债务IIPRSLNO
| Q4 25 | $393.7M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IIPRSLNO
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.9B | $494.8M | ||
| Q2 25 | $1.9B | $240.1M | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $1.9B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.9B | — | ||
| Q1 24 | $2.0B | — |
总资产IIPRSLNO
| Q4 25 | $2.4B | — | ||
| Q3 25 | $2.3B | $599.9M | ||
| Q2 25 | $2.3B | $332.3M | ||
| Q1 25 | $2.4B | — | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | $2.4B | — | ||
| Q2 24 | $2.4B | — | ||
| Q1 24 | $2.4B | — |
负债/权益比IIPRSLNO
| Q4 25 | 0.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $198.2M | $43.5M |
| 自由现金流经营现金流 - 资本支出 | — | $43.5M |
| 自由现金流率自由现金流/营收 | — | 65.8% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 6.22× | 1.67× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流IIPRSLNO
| Q4 25 | $198.2M | — | ||
| Q3 25 | $45.6M | $43.5M | ||
| Q2 25 | $48.4M | $-12.6M | ||
| Q1 25 | $54.2M | — | ||
| Q4 24 | $258.4M | — | ||
| Q3 24 | $64.9M | — | ||
| Q2 24 | $64.2M | — | ||
| Q1 24 | $71.6M | — |
自由现金流IIPRSLNO
| Q4 25 | — | — | ||
| Q3 25 | — | $43.5M | ||
| Q2 25 | — | $-12.6M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率IIPRSLNO
| Q4 25 | — | — | ||
| Q3 25 | — | 65.8% | ||
| Q2 25 | — | -38.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度IIPRSLNO
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率IIPRSLNO
| Q4 25 | 6.22× | — | ||
| Q3 25 | 1.56× | 1.67× | ||
| Q2 25 | 1.86× | — | ||
| Q1 25 | 1.75× | — | ||
| Q4 24 | 6.46× | — | ||
| Q3 24 | 1.61× | — | ||
| Q2 24 | 1.53× | — | ||
| Q1 24 | 1.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
